BackSarepta Therapeutics Overview

Sarepta Therapeutics Current Cash

Sarepta Therapeutics's current cash is $570M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$571.15M
↑ 11.86% YoYΔ $60.55M vs prior year quarter

Peer trimmed avg / median

Loading

Sarepta Therapeutics Current Cash History

Loading

Sarepta Therapeutics vs. peers: Current Cash Comparison

Loading

Sarepta Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Sarepta Therapeutics (SRPT) FAQ

As of the most recent data (June 2026), SRPT shows a current cash of $570M. That compares with $510M in the prior-year period — up 11.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SRPT's current cash is now $570M (was $510M) — a 11.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Sarepta Therapeutics is outperforming or lagging.

Tracking SRPT's current cash over time shows whether Sarepta Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $570M That compares with $510M in the prior-year period — up 11.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Sarepta Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $570M) with ownership activity and broader fundamentals.

Sarepta Therapeutics's current cash is $570M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.